Related Experiment Videos
Summary
Sentinel lymph node biopsy accurately detects penile cancer metastasis. This minimally invasive procedure can help determine the extent of cancer spread, guiding treatment decisions for patients with squamous cell carcinoma.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Penile cancer, particularly invasive squamous cell carcinoma, poses a risk of regional lymph node metastasis.
- Accurate staging of lymph node involvement is crucial for effective treatment planning and prognosis.
Purpose of the Study:
- To evaluate the efficacy of sentinel lymph node biopsy (SLNB) in detecting lymphatic metastasis in penile cancer patients.
- To assess the reliability of SLNB in identifying the first site of regional spread.
Main Methods:
- Sentinel lymph node biopsies were performed on 10 patients with invasive squamous cell carcinoma of the penis.
- Biopsies were analyzed for the presence of metastatic cancer cells.
- Follow-up included regional lymphadenectomy and surveillance for tumor recurrence.
Main Results:
- Of 15 biopsies in patients with inguinal lymphadenopathy, 5 were positive.
- Two of 3 biopsies in patients with clinically normal inguinal nodes were positive.
- In 7 patients undergoing lymphadenectomy after a positive biopsy, only 1 had additional metastases.
- Five patients with negative bilateral biopsies remained disease-free with a mean follow-up of 26 months.
Conclusions:
- Sentinel lymph node biopsy appears to be a reliable method for detecting early lymphatic spread in penile cancer.
- SLNB can potentially spare patients from unnecessary extensive lymphadenectomies.
- These findings suggest the sentinel lymph node is frequently the initial site of metastasis in penile cancer.